BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.14
Delayed Data
As of Apr 18
 -0.04 / -0.77%
Today’s Change
3.95
Today|||52-Week Range
7.39
+4.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues9.4M3.1M8.8M3.9M
 
 
 
 
 
Cost of Goods Sold122.0K22.0K1.1M38.0K
 
 
 
 
 
Depreciation And Amortization172.0K172.0K178.0K182.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.1M2.9M7.5M3.7M
 
 
 
 
 
General Expenses19.8M18.4M20.9M21.5M
 
 
 
 
 
Research And Development16.8M15.8M17.5M16.9M
 
 
 
 
 
Total Operating Expenses20.1M18.6M22.1M21.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-15.5M-13.3M-17.9M
 
 
 
 
 
Extraordinary Credit0.00521.0K130.0K71.0K
 
 
 
 
Extraordinary Charge-1.5M0.000.000.00
 
 
Interest Expense On Debt2.1M2.1M2.1M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.2M-16.9M-15.1M-19.5M
 
 
 
 
 
Net Income-14.2M-16.9M-15.1M-19.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS75.2M80.4M83.6M98.4M
 
 
 
 
 
Shares To Calculate EPS Diluted75.2M80.4M83.6M98.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.21-$0.18-$0.20
 
 
 
 
 
EPS Diluted-$0.19-$0.21-$0.18-$0.20